F2RL1 and ovarian cancer: Hence, knockdown of Par2 (Figure 3A) or blocking of PAR2-mediated cell signaling via the Pc(4-4)compound (Figure 6C) both resulted in significant inhibition of ovarian cancer growth and peritoneal dissemination.